Back to directory

Medical Creatine Formulations

Prescription or clinical-grade creatine protocols tailored for creatine transporter (SLC6A8), AGAT, or GAMT deficiencies, often combined with arginine, glycine, or sodium benzoate.

Patients with inborn errors of creatine metabolism require specialized dosing, often via pharmaceutical-grade creatine monohydrate, guanidinoacetate restriction, or experimental derivatives.

Clinical only
Restore brain creatine levels
Arginine, glycine, ornithine, or sodium benzoate

Who it helps most

  • Patients diagnosed with creatine deficiency syndromes under metabolic specialist care

Limitations & cautions

  • Not general-use supplements
  • Require genetic testing and lab monitoring
  • Insurance or compassionate-use programs may govern access

Therapeutic responses vary by deficiency type

Nature Genetics reviews and GeneReviews note that AGAT and GAMT deficiencies respond well to high-dose creatine, whereas transporter deficiencies need experimental delivery strategies.

How treatment differs from sports use

Doses may reach 0.3–0.8 g/kg/day initially, far exceeding sports protocols, and are often combined with low-protein or low-guanidinoacetate diets. Medical supervision is mandatory.

Emerging therapeutics

Researchers are experimenting with lipophilic creatine analogues, intranasal delivery, and transporter bypass strategies to improve brain uptake for SLC6A8 deficiency.

Why athletes should take note

These formulations illustrate the direction of future creatine innovation but are not substitutes for consumer supplements due to dosing, purity, and prescription requirements.

Individualized; often 400–800 mg/kg/day split into 4–6 doses in AGAT/GAMT deficiency, per metabolic specialist orders.

Hospital pharmacies or compounding pharmacies following pharmacopeia standards.

Compare with other creatine formats to find the best fit for your needs.

View all creatine types →
  • Nature – Laboratory diagnosis of creatine deficiency syndromes

    Explains diagnostic pathways and treatments.

    Visit source
  • PubMed – Response to therapy of creatine transporter deficiency

    Reports on therapeutic trials and outcomes.

    Visit source
  • GeneReviews – Creatine Deficiency Disorders

    Comprehensive clinical guidance.

    Visit source